FOGHORN THERAPEUTICS INC's ticker is FHTX and the CUSIP is 344174107. A total of 61 filers reported holding FOGHORN THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $353,660 | -30.0% | 70,732 | -1.5% | 0.00% | – |
| Q2 2023 | $505,381 | +14.8% | 71,787 | +1.1% | 0.00% | – |
| Q1 2023 | $440,399 | -2.8% | 71,032 | -0.0% | 0.00% | – |
| Q4 2022 | $453,286 | -20.3% | 71,048 | +7.3% | 0.00% | – |
| Q3 2022 | $569,000 | -17.9% | 66,237 | +29.9% | 0.00% | – |
| Q2 2022 | $693,000 | -25.6% | 50,983 | -16.6% | 0.00% | – |
| Q1 2022 | $931,000 | -59.9% | 61,113 | -39.8% | 0.00% | – |
| Q4 2021 | $2,319,000 | +213.4% | 101,439 | +91.0% | 0.00% | – |
| Q3 2021 | $740,000 | +34.8% | 53,118 | +3.3% | 0.00% | – |
| Q2 2021 | $549,000 | +114.5% | 51,419 | +164.5% | 0.00% | – |
| Q1 2021 | $256,000 | -30.2% | 19,440 | +7.5% | 0.00% | – |
| Q4 2020 | $367,000 | – | 18,086 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Capital LLC | 1,261,261 | $25,566,000 | 5.41% |
| Flagship Pioneering Inc. | 12,674,120 | $256,905,000 | 4.68% |
| Birchview Capital, LP | 314,143 | $6,368,000 | 3.67% |
| Monashee Investment Management LLC | 560,360 | $11,359,000 | 1.50% |
| Artal Group S.A. | 1,720,720 | $34,879,000 | 0.75% |
| Alphabet Inc. | 500,901 | $10,153,000 | 0.49% |
| Cormorant Asset Management, LP | 1,000,000 | $20,270,000 | 0.48% |
| Casdin Capital, LLC | 216,216 | $4,383,000 | 0.13% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 258,700 | $5,244,000 | 0.08% |
| Woodline Partners LP | 103,040 | $2,089,000 | 0.06% |